Goals of 1st Indian Cancer Congress

Dr Ashok K. Vaid - Medanta The Medicity, Haryana, India
Goals of 1st Indian Cancer Congress ( Dr Ashok K. Vaid - Medanta The Medicity, Haryana, India )
5 Dec 2013

Quality of life after robotic surgery treatment for prostate cancer

Dr Rajiv Yadav - Medanta The Medicity, Haryana, India
Quality of life after robotic surgery treatment for prostate cancer ( Dr Rajiv Yadav - Medanta The Medicity, Haryana, India )
4 Dec 2013

Immuno-Oncology: the next new paradigm in cancer treatment? Chairman's welcome and introduction

Prof. Winald Gerritsen - Radboud University Nijmegen Medical Centre, The Netherlands
Immuno-Oncology: the next new paradigm in cancer treatment? Chairman's welcome and introduction ( Prof. Winald Gerritsen - Radboud University Nijmegen Medical Centre, The Netherlands )
3 Dec 2013

Cancer cells and the immune system: a natural story?

Prof. Laurence Zitvogel - INSERM, Institut Gustave Roussy, Villejuif, France
Cancer cells and the immune system: a natural story? ( Prof. Laurence Zitvogel - INSERM, Institut Gustave Roussy, Villejuif, France )
3 Dec 2013

Why are Immuno-Oncology compounds different?

Prof. Enriqueta Felip - Vall d'Hebron University Hospital, Barcelona, Spain
Why are Immuno-Oncology compounds different? ( Prof. Enriqueta Felip - Vall d'Hebron University Hospital, Barcelona, Spain )
3 Dec 2013

Immuno-Oncology: a concept or already a reality?

Prof. Peter Johnson - Cancer Research UK Centre, University of Southampton, UK
Immuno-Oncology: a concept or already a reality? ( Prof. Peter Johnson - Cancer Research UK Centre, University of Southampton, UK )
3 Dec 2013

Palliative care in advanced prostate cancer

Dr Zipporah Ali - Kenya Hospices and Palliative Care Association (KEHPCA), Kenya
Palliative care in advanced prostate cancer ( Dr Zipporah Ali - Kenya Hospices and Palliative Care Association (KEHPCA), Kenya )
27 Nov 2013

Overview of the AORTIC 2013 scientific programme

Dr Seringe Gueye - Hospital General de Grand Yoff, Senegal
Overview of the AORTIC 2013 scientific programme ( Dr Seringe Gueye - Hospital General de Grand Yoff, Senegal )
27 Nov 2013

Comparing toxicity profiles for 72 hour infusional and conventional bleomycin in testicular cancer

Dr Jonathan Shamash - Barts Cancer Institute, London, UK
Comparing toxicity profiles for 72 hour infusional and conventional bleomycin in testicular cancer ( Dr Jonathan Shamash -  Barts Cancer Institute, London, UK )
15 Nov 2013

Engineering of polymeric nanoparticles for medical applications

Dr Omid Farokhzad - Harvard Medical School, Boston, USA
Engineering of polymeric nanoparticles for medical applications ( Dr Omid Farokhzad - Harvard Medical School, Boston, USA )
14 Nov 2013

DIfferences in prostate treatment between ROI and Northern Ireland, and measuring patient opinions

Dr Anna Gavin - North Ireland Cancer Registry, Queens University, Belfast, UK
DIfferences in prostate treatment between ROI and Northern Ireland, and measuring patient opinions ( Dr Anna Gavin - North Ireland Cancer Registry, Queens University, Belfast, UK )
13 Nov 2013

The NCRN Pomi-T study: polyphenol rich whole food supplement slows PSA progression in prostate cancer

Dr Robert Thomas - Cambridge University Hospitals, UK
The NCRN Pomi-T study: polyphenol rich whole food supplement slows PSA progression in prostate cancer ( Dr Robert Thomas - Cambridge University Hospitals, UK )
12 Nov 2013